DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Pluristem Therapeutics, Inc. (PSTI)
« Back to company indexPSTI Chatter Timeline
Stock Ticker for PSTI
Most Active Tweeters for PSTI
| User | Tweets |
|---|---|
| @GantosJ | 7 |
| @fierro7676 | 4 |
| @AmericanBanking | 3 |
| @TickerReport | 3 |
| @ConsumerFeed | 3 |
Recent Tweets for PSTI
 |
@ThisLincolnian Maxim Group Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/A3RRgeAX3h December 7th 2019, 11:12am |
 |
@ConsumerFeed Pluristem Therapeutics $PSTI Rating Reiterated by Maxim Group https://t.co/V1hzcSXSJF December 6th 2019, 4:12am |
 |
@GantosJ $PSTI is an important part of RESTORE.... Competing for an award up to €1 billion over the next 10 years by the Eu… https://t.co/02SxB4i82a December 5th 2019, 9:12am |
 |
@TickerReport Pluristem Therapeutics’ $PSTI “Buy” Rating Reaffirmed at Maxim Group https://t.co/AV3gQKXEra December 4th 2019, 2:12pm |
 |
@AmericanBanking Maxim Group Reiterates “Buy” Rating for Pluristem Therapeutics $PSTI https://t.co/HhJb6yLn0l #stocks December 4th 2019, 2:12pm |
 |
@MaisaCorp $PSTI has enrolled half of the targeted 240 patients for the ongoing phase 3 trial of its placenta-based cell thera… https://t.co/LtSib7KAeu December 3rd 2019, 6:12pm |
|
@GantosJ So we got the continuation candlestick today in $PSTI & closing at the HoD $3.80 on large volume Waiting for BARDA… https://t.co/cjMqNXgOmA December 3rd 2019, 4:12pm |
 |
@LifeSciAdvisors Pluristem $PSTI Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/wIsIAJECSW December 3rd 2019, 3:12pm |
 |
@fierro7676 RT @GantosJ: $PSTI Many patients do not fully recover after surgery, suffering considerable morbidity due to poor muscle regeneration and i… December 3rd 2019, 3:12pm |
|
@fierro7676 RT @GantosJ: $PSTI Currently no approved treatments for the post-operative regeneration of injured or weak skeletal muscle & up to 30% of… December 3rd 2019, 3:12pm |
|
@fierro7676 $PSTI looks ready to run https://t.co/ZpZ9zpkzcC December 3rd 2019, 3:12pm |
|
@GantosJ $PSTI breaking out the 50MA & downtrend line & closing above them. We need a confirmation candle today thoug Next t… https://t.co/n9XTtr9yZk December 3rd 2019, 8:12am |
|
@GantosJ $PSTI Many patients do not fully recover after surgery, suffering considerable morbidity due to poor muscle regener… https://t.co/A6fRbNRxWA December 3rd 2019, 8:12am |
|
@GantosJ $PSTI Currently no approved treatments for the post-operative regeneration of injured or weak skeletal muscle & up… https://t.co/oDOyxNFvzF December 3rd 2019, 7:12am |
 |
@Gambiste1 RT @Optionsavvy: $PSTI looking perky premarket at 3.66 December 3rd 2019, 7:12am |
 |
@otcdynamics $PSTI Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/idVPKce7vI December 3rd 2019, 7:12am |
 |
@Optionsavvy $PSTI looking perky premarket at 3.66 December 3rd 2019, 7:12am |
 |
@catfish456 PSTI - 3.61 Pre-market now at 3.66/3.70 Pluristem Completes 50% Enrollment In Phase III PLX-PAD Mus $PLX $PSTI… https://t.co/IoU0Kik9bR December 3rd 2019, 7:12am |
|
@GantosJ $PSTI Reaches Milestone in its Ph-3 Muscle Injury Study, Completes 50% Enrollment Multinational study in the U.S.,… https://t.co/rs2MVCdp3q December 3rd 2019, 7:12am |
 |
@DekmarTrades $ALDX and $PSTI are the two best PRs of 7am. December 3rd 2019, 7:12am |
 |
@VisualStockRSRC $PSTI - Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/Umgvd1EY7s December 3rd 2019, 7:12am |
|
@ThisLincolnian Pluristem Therapeutics $PSTI Trading 7.8% Higher https://t.co/vQLXchkUTW December 2nd 2019, 8:12pm |
 |
@WeekHerald Pluristem Therapeutics $PSTI Trading Up 7.8% https://t.co/7B5Lz1Xy7p December 2nd 2019, 8:12pm |
 |
@dailypoliticaln Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/wkTuQ8SA1w December 1st 2019, 7:12pm |
 |
@dispatchtribune Short Interest in Pluristem Therapeutics Inc. $PSTI Drops By 22.1% https://t.co/ooz12IQRrw November 29th 2019, 6:11pm |
 |
@OlympiaReport Short Interest in Pluristem Therapeutics Inc. $PSTI Drops By 22.1% https://t.co/Mlqemf85Ci November 29th 2019, 6:11pm |
|
@dailypoliticaln Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/DHx1ogAa0W November 29th 2019, 5:11pm |
|
@TickerReport Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/L1015mj0qJ November 29th 2019, 5:11pm |
 |
@ZolmaxNews -$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/kU8PVPVE6h November 29th 2019, 4:11pm |
|
@Gambiste1 RT @botpicks: Should I Go Long or Short $PSTI ? November 29th 2019, 3:11am |
 |
@botpicks Should I Go Long or Short $PSTI ? November 29th 2019, 1:11am |
|
@ConsumerFeed Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/ynCn3cEsGY November 27th 2019, 3:11pm |
|
@AmericanBanking Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/jeTVl36IIb #stocks November 27th 2019, 3:11pm |
 |
@WatchlistN Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/dKiTqZeE8n November 27th 2019, 3:11pm |
 |
@PatentGrants $PSTI Pluristem Therapeutics granted European patent number EP2697362 titled "METHODS AND SYSTEMS FOR HARVESTING CE… https://t.co/jCn8iZ8RwN November 27th 2019, 11:11am |
|
@ConsumerFeed Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/jx3Ajc7cuJ November 27th 2019, 5:11am |
 |
@bbnsnews Zacks: Brokerages Anticipate Pluristem Therapeutics Inc. $PSTI to Post -$0.80 EPS https://t.co/F8ToSFT9mO November 27th 2019, 5:11am |
|
@fierro7676 RT @GantosJ: $PSTI Stochastics breaking out its downtrend line, usually used as an early indicator of share-price breaking out downtrend li… November 26th 2019, 11:11am |
|
@GantosJ $PSTI Stochastics breaking out its downtrend line, usually used as an early indicator of share-price breaking out d… https://t.co/GyELWQPtzQ November 26th 2019, 11:11am |
 |
@stocknewstimes Editas Medicine $EDIT vs. Pluristem Therapeutics $PSTI Head to Head Analysis https://t.co/PBcqJomHAt November 26th 2019, 3:11am |
 |
@TheMarketsDaily Reviewing Editas Medicine $EDIT and Pluristem Therapeutics $PSTI https://t.co/e0LcJNjoJN November 26th 2019, 3:11am |
|
@AmericanBanking -$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/Awm3jxdUJQ #stocks November 24th 2019, 7:11pm |
|
@TheMarketsDaily Zacks: Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Announce Earnings of -$0.80 Per Share https://t.co/G4tntZ3rb8 November 24th 2019, 7:11pm |
 |
@dakotafinancial -$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/9GyGu34rxn November 24th 2019, 7:11pm |
|
@dakotafinancial Pluristem Therapeutics $PSTI Share Price Crosses Above Two Hundred Day Moving Average of $2.55 https://t.co/MvOVb1UJQr November 24th 2019, 7:11am |
|
@TickerReport Head to Head Survey: Pluristem Therapeutics $PSTI and Editas Medicine $EDIT https://t.co/jXbKQYpvB0 November 24th 2019, 4:11am |
|
@dailypoliticaln Pluristem Therapeutics $PSTI Shares Cross Above Two Hundred Day Moving Average of $2.55 https://t.co/TDIREuLwen November 22nd 2019, 7:11pm |
|
@ZolmaxNews Pluristem Therapeutics $PSTI Stock Crosses Above 200-Day Moving Average of $2.55 https://t.co/Q9J0bZIVit November 22nd 2019, 6:11pm |
 |
@intercooleronli HC Wainwright Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/eeOJX4URIH #investingnews November 18th 2019, 1:11am |
 |
@ledgerzette HC Wainwright Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/olRufcg4rd #stocks November 18th 2019, 1:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.